143P Efficacy and safety of bronchial arterial chemoembolization (BACE) in combination with tislelizumab for non-small cell lung cancer (NSCLC): A single-arm phase II trial. (December 2022) - Duan, X.; Li, H.; Kuang, D.; Zhang, M.; Xu, W.; Liang, C.; Wang, J.; Ren, J.